Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Background Only a third of patients with depression respond fully to antidepressant medication but little evidence exists regarding the best next-step treatment for those whose symptoms are treatment resistant. The CoBalT trial aimed to examine the effectiveness of cognitive behavioural therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment resistant depression compared with usual care alone. Methods This two parallel-group multicentre randomised controlled trial recruited 469 patients aged 18-75 years with treatment resistant depression (on antidepressants for ≥6 weeks, Beck depression inventory [BDI] score ≥14 and international classification of diseases [ICD]-10 criteria for depression) from 73 UK general practices. Participants were randomised, with a computer generated code (stratified by centre and minimised according to baseline BDI score, whether the general practice had a counsellor, previous treatment with antidepressants, and duration of present episode of depression) to one of two groups: usual care or CBT in addition to usual care, and were followed up for 12 months. Because of the nature of the intervention it was not possible to mask participants, general practitioners, CBT therapists, or researchers to the treatment allocation. Analyses were by intention to treat. The primary outcome was response, defined as at least 50% reduction in depressive symptoms (BDI score) at 6 months compared with baseline. This…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of studies have shown that initiating treatment with both psychotherapy and pharmacotherapy produces significantly better outcomes than either treatment alone 169,170 .”
From Major depressive disorder (2016) · cites this paper as [170]
In the citing paper
“With more than 40 original reports and meta-analyses published on CBT for MDD or PDD since 2009, there is substantial evidence of efficacy even in severely affected individuals and in those who had not responded to treatment with antidepressants.62,63”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [63]
In the citing paper
“An RCT of 469 primary care patients with depression with poor response to medication found CBT improved response and remission, 63 with sustained effects at 3-year follow-up.89”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [63]
In the citing paper
“CBT is also effective for people with treatment-resistant depression (i.e., those who did not respond to at least 2 adequate antidepressant trials).”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [63]
In the citing paper
“In summary, CBT or MBCT is recommended as sequential first-line treatment (Level 1 Evidence) after a course of antidepressants”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [63]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Cognitive Therapy: Basics and Beyond
Beck, J. S. (1995) · Medical Entomology and Zoology · Cited by 3,321
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695
Cognitive Therapy of Depression
Fischer, H. K. (1980) · Psychosomatics · doi:10.1016/s0033-3182(80)73639-3 · Cited by 1,612
Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. (1992) · Psychological Medicine · doi:10.1017/s0033291700030415 · Cited by 1,487
Self-citationKeller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331
Prevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735
The revised cognitive therapy scale (CTS-R): psychometric properties.
Blackburn, I.-M., James, I. A., Milne, D. L., Baker, C., Standart, S., Garland, A., & Reichelt, F. K. (2001) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465801004040 · Cited by 568
Self-citationChurchill, R., Hunot, V., Corney, R., Knapp, M., McGuire, H., Tylee, A., & Wessely, S. (2002) · Health Technology Assessment · doi:10.3310/hta5350 · Cited by 368
Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, M. H., Luther, J. F., Fava, M., Nierenberg, A. A., McGrath, P. J., Warden, D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.739 · Cited by 332
Design and analysis of clinical trials with clustering effects due to treatment
Roberts, C., & Roberts, S. A. (2005) · Clinical Trials · doi:10.1191/1740774505cn076oa · Cited by 299
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
National Trends in the Use of Outpatient Psychotherapy
Olfson, M., Marcus, S. C., Druss, B., & Pincus, H. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1914 · Cited by 249
Kocsis, J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.144 · Cited by 214
Dunn, G., Maracy, M., & Tomenson, B. (2005) · Statistical Methods in Medical Research · doi:10.1191/0962280205sm403oa · Cited by 201
Compliance with tricyclic antidepressants: the value of four different methods of assessment
George, C. F., Peveler, R. C., Heiliger, S., & Thompson, C. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00244.x · Cited by 174
Secular trends in antidepressant prescribing in the UK, 1975-1998
Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001) · Journal of Public Health · doi:10.1093/pubmed/23.4.262 · Cited by 168
Stimpson, N., Agrawal, N., & Lewis, G. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.4.284 · Cited by 157
Self-citationAssessing psychiatric disorder with a human interviewer or a computer.
Lewis, G. (1994) · Journal of Epidemiology and Community Health · doi:10.1136/jech.48.2.207 · Cited by 150
Self-citationRecent trends in the use of antidepressant drugs in Australia, 1990–1998
McManus, P., Mant, A., Mitchell, P. B., Montgomery, W. S., Marley, J., & Auland, M. E. (2000) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139294.x · Cited by 131
Minimization–reducing predictability for multi-centre trials whilst retaining balance within centre
Brown, S., Thorpe, H., Hawkins, K., & Brown, J. (2005) · Statistics in Medicine · doi:10.1002/sim.2391 · Cited by 97
Thase, M. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.5.739 · Cited by 76
Cognitive Therapy for Chronic and Persistent Depression
Moore, R. G., & Garland, A. (2003) · Wiley eBooks · doi:10.1002/9780470713495 · Cited by 74
Self-citationMcPherson, S., Cairns, P., Carlyle, J., Shapiro, D. A., Richardson, P., & Taylor, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00498.x · Cited by 66
Thomas, L., Abel, A., Ridgway, N., Peters, T., Kessler, D. S., Hollinghurst, S. P., Turner, K. M., Garland, A., Jerrom, B., Morrison, J., et al. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.10.016 · Cited by 43
Self-citationWiles, N. J., Hollinghurst, S., Mason, V., Musa, M., Burt, V., Hyde, J., Jerrom, B., Lewis, G., & Kessler, D. (2008) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246580700389x · Cited by 33
Self-citationKennedy, S. H., Segal, Z. V., Cohen, N. L., Levitan, R. D., Gemar, M., & Bagby, R. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0414 · Cited by 25
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20
Self-citationUsual Care Psychotherapy for Depression in a Large Managed Behavioral Health Organization
Hepner, K. A., Greenwood, G. L., Azocar, F., Miranda, J. M., & Burnam, M. A. (2009) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-009-0247-6 · Cited by 18
Combined cognitive-behavioral and pharmacotherapy in refractory depression
Strauß, W. H. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)87527-4 · Cited by 5
Cited by
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
“Recently the CoBalT study specifically compared outcomes in 469 primary care patients with at least mild depression (BDI score ⩾14 after 6 weeks of adequate antidepressant treatment) randomised to add-on CBT or TAU (Wiles et al., 2013).”
ResultSelf-citationRichards, D. A., Ekers, D., McMillan, D., Taylor, R. S., Byford, S., Warren, F. C., Barrett, B., Farrand, P. A., Gilbody, S., Kuyken, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31140-0 · Cited by 595
Self-citationParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
“With more than 40 original reports and meta-analyses published on CBT for MDD or PDD since 2009, there is substantial evidence of efficacy even in severely affected individuals and in those who had not responded to treatment with antidepressants.(62,63) Similarly, there is evidence across populations (adult, adolescen…”
Background
Metadata
- Authors
- Wiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., Garland, A., Hollinghurst, S., Jerrom, B., Kessler, D., Kuyken, W., Morrison, J., Turner, K., Williams, C., Peters, T., & Lewis, G.
- Affiliations
- University of Bristol (GB)
- University of Exeter (GB)
- University of Glasgow (GB)
- Nottinghamshire Healthcare NHS Foundation Trust (GB)
- Avon and Wiltshire Mental Health Partnership NHS Trust (GB)
- Corresponding author
- Wiles, Nicola
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 381
- Issue
- 9864
- Pages
- 375-384
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2140815719
- Semantic Scholar
- 6053cd99d79fa39a9a06da8e88d770e6fa6c1c5e
- Cited by
- 340
- References
- 40
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 18 · 2023: 17 · 2022: 17 · 2021: 19 · 2020: 35 · 2019: 30 · 2018: 27 · 2017: 26 · 2016: 39 · 2015: 30 · 2014: 36 · 2013: 25
- FWCI
- 21.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Open Research Exeter (University of Exeter) (publishedVersion)
- Explore Bristol Research (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- National Institute for Health and Care Research (06/404/501, MET-11-21-101)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- treatment-resistant depression, cognitive behavioral therapy, antidepressant augmentation, pharmacotherapy, primary care, usual care, depressive symptoms
- MeSH terms
- Adult, Antidepressive Agents, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Primary Health Care, Cognitive Behavioral Therapy, Treatment Outcome, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.